Business Today
Subscribe
NRICareer & JobsUS NewsIn PicsWeatherPetrol PricesDiesel PricesPMS TodayBT Reels
BT India at 100BT Infra SummitEY Business Today Hidden Gems 2026
Search
Advertisement
Business News
markets
stocks
Molbio Diagnostics Ltd
Molbio Diagnostics Ltd

Molbio Diagnostics Ltd (MOLBIO) Share Price

  • Sector: Healthcare (Small Cap)
  • Volume: 38,01,397
Sep 18, 2026
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1,288.30
₹3.00 (0.23%)
1,262.20Low
Today’s Performance
1,314.80High
926.35Low
52 Week’s Performance
1,686.80High

Stock Analysis

Stock Performance

  • 1 Day0.23%
  • 1 Week-10.42%
  • 1 Month15.97%
  • 3 Months23.67%
  • 6 Months-%
  • 1 Year-%
  • 3 Years-%
  • 5 Years-%

Stock Summary

  • Face Value (₹)1.00
  • Beta0.82
  • 52-Week Low (₹)926.35
  • 52-Week High (₹)1,686.80
  • Price-to-Book (X)*10.84
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*90.49
  • Earnings Per Share (₹)14.24
  • Market Cap (₹ Cr.)*14,846.37
* Values as of last close price

COMPETITORS

BT TV

Gold Price Target 2026: Expert Sees MCX Gold At ₹1.8 Lakh By Year-End Amid Strong Demand1:35Gold Price Target 2026: Expert Sees MCX Gold At ₹1.8 Lakh By Year-End Amid Strong Demand
Health Insurance: Why Pre-Existing Diseases And Waiting Periods Matter For Buyers2:12Health Insurance: Why Pre-Existing Diseases And Waiting Periods Matter For Buyers
Crude Oil Above $100: How High Energy Prices And Rupee Weakness Impact Gold Prices In India2:20 Crude Oil Above $100: How High Energy Prices And Rupee Weakness Impact Gold Prices In India
CEA On India’s Manufacturing Rise, Atmanirbhar Bharat And Modi’s Economic Policy4:35CEA On India’s Manufacturing Rise, Atmanirbhar Bharat And Modi’s Economic Policy
Health Insurance Buying Guide: 7 Things First-Time Buyers Must Check Before Choosing A Policy2:16Health Insurance Buying Guide: 7 Things First-Time Buyers Must Check Before Choosing A Policy
CEA On India’s 7.8% Growth, Rural Incomes And Government’s Job Creation Push6:20CEA On India’s 7.8% Growth, Rural Incomes And Government’s Job Creation Push
Gold Price Outlook: Why Dollar Weakness Could Keep Gold And Silver Prices Attractive Ahead2:05Gold Price Outlook: Why Dollar Weakness Could Keep Gold And Silver Prices Attractive Ahead
Gold Vs Silver Investment Strategy: Is This The Right Time To Buy For Long-Term Returns?2:24Gold vs Silver Investment Strategy: Is This The Right Time To Buy For Long-Term Returns?
Corporate Vs Personal Health Insurance: Which Is Better On A Budget?1:14Corporate Vs Personal Health Insurance: Which Is Better On A Budget?
Gold Price Outlook: Why Gold Could Rise Despite Global Interest Rate Hikes | Silver Market Update2:17Gold Price Outlook: Why Gold Could Rise Despite Global Interest Rate Hikes | Silver Market Update
View more

FAQs

What was Molbio Diagnostics Ltd share price previously?
Molbio Diagnostics Ltd share price was up by 0.23% from the previous closing price of ₹1,285.30.
Who are peers of Molbio Diagnostics Ltd?
The peers of Molbio Diagnostics Ltd are Apollo Hospitals Enterprise Ltd, Max Healthcare Institute Ltd, Manipal Health Enterprises Ltd, Fortis Healthcare Ltd, Aster DM Healthcare Ltd.
Who is/are the promoter/promoters of Molbio Diagnostics Ltd?
The promotor/promotors of Molbio Diagnostics Ltd are SRIRAM NATARAJAN, CHANDRASEKHAR NAIR, SANGEETHA SRIRAM, Arun Kumar Jha, Dr Balram Bhargava, Nupur Garg, Darshan Raghunath Karekar.
What has been 52-week high of Molbio Diagnostics Ltd stocks?
The highest price of Molbio Diagnostics Ltd stock is ₹1,686.80 in the last 52-week.
What is the share price of Molbio Diagnostics Ltd (MOLBIO) today on NSE?
As on Sep 18, 2026 Molbio Diagnostics Ltd (MOLBIO)’s share price on NSE is Rs 1288.3
What is the market cap of Molbio Diagnostics Ltd (MOLBIO)?
The current market capitalisation of Molbio Diagnostics Ltd (MOLBIO) is 14,846.37 crores
What is Molbio Diagnostics Ltd Share symbol?
The symbol of Molbio Diagnostics Ltd is MOLBIO.
What is the PE ratio of Molbio Diagnostics Ltd (MOLBIO)?
The current PE ratio of Molbio Diagnostics Ltd (MOLBIO) is 90.49.
What is the PB ratio of Molbio Diagnostics Ltd (MOLBIO)?
The current PB ratio of Molbio Diagnostics Ltd (MOLBIO) is 10.84.
Today’s High & Low share prices of Molbio Diagnostics Ltd (MOLBIO) on NSE?
Today, the share price of Molbio Diagnostics Ltd (MOLBIO) on NSE touched a high of Rs 1314.8 and a low of Rs 1262.2
What price did Molbio Diagnostics Ltd (MOLBIO) shares open on the NSE today?
On NSE, the share price of Molbio Diagnostics Ltd (MOLBIO) opened at Rs 1297.1
What is the 52-week high of Molbio Diagnostics Ltd (MOLBIO)?
The 52-week high price of Molbio Diagnostics Ltd (MOLBIO) is Rs 1,686.80
What is the 52-week low of Molbio Diagnostics Ltd (MOLBIO)?
The 52-week low price of Molbio Diagnostics Ltd (MOLBIO) is Rs 926.35

About Molbio Diagnosti

Molbio Diagnostics Ltd, incorporated in the year 2000, has its registered office in No.L-46 Phase II-D, Verna Industrial Area Verna, Salcete, Goa, 403722, +91 832 6724 888. The main industry in which Molbio Diagnostics Ltd operates is Healthcare.

Auditor/Auditors for Molbio Diagnostics Ltd is/are S R Batliboi & Associates LLP. In the main management, is chairman and Darshan Raghunath Karekar is the company secretary for Molbio Diagnostics Ltd.

  • SN
    SRIRAM NATARAJANExecutive Director & CEO
  • CN
    CHANDRASEKHAR NAIRExecutive Director / Chief Technology Officer
  • SS
    SANGEETHA SRIRAMExecutive Director (Operation)
  • AKJ
    Arun Kumar JhaIndependent Non Exe. Director
  • DBB
    Dr Balram BhargavaIndependent Non Exe. Director
  • NG
    Nupur GargIndependent Non Exe. Director
  • DRK
    Darshan Raghunath KarekarCompany Sec. & Compli. Officer

Top Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.